Full-Time

Regional Sales Manager

West

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$140k - $180kAnnually

Senior

Western United States, USA

Field-based position in the West Region.

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Requirements
  • Bachelor’s degree in business, marketing, or a related field.
  • Minimum of 5+ years of sales experience in the pharmaceutical or biotech industry
  • 2+ years of experience in a leadership or sales management role.
  • 2+ years of experience in cardiometabolic and/or rare disease sales.
  • Demonstrated success in developing and leading high-performing teams, meeting or exceeding sales targets, and driving territory growth.
  • Experience with product launches and a deep understanding of the regional healthcare market.
  • Strong communication, leadership, and strategic thinking skills.
  • Must live within a reasonable distance of a major airport to ensure ease of travel for work-related assignments
  • Willingness and ability to travel frequently
Responsibilities
  • Lead and Manage Regional Sales Team
  • Recruit, train, and manage a team of Sales Representatives to achieve and exceed sales targets.
  • Provide ongoing coaching and performance feedback, fostering a culture of motivation and accountability.
  • Conduct regular field visits and lead sales team meetings to ensure alignment with strategic goals.
  • Implement and Execute Regional Sales Strategies
  • Develop and execute regional business plans, ensuring alignment with national goals and strategic initiatives.
  • Monitor sales performance against established targets and adjust strategies as needed to ensure success.
  • Ensure efficient resource allocation within the region to meet business objectives and maximize sales impact.
  • Build and Maintain Stakeholder Relationships
  • Build and maintain strong relationships with key external stakeholders, including healthcare professionals, payers, and other relevant partners within the region.
  • Cultivate a culture of compliance, ensuring adherence to corporate policies, procedures, and all legal and regulatory standards.
  • Maintain high training standards for the field team.
  • Foster a Culture of Compliance
  • Ensure adherence to corporate policies, regulatory guidelines, and industry best practices across the regional sales team.
  • Implement training and development programs that emphasize compliance and ethical selling practices
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse the progression of diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure deep and lasting effects on target genes. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. Their goal is to provide new options for patients suffering from genetic disorders, and they generate revenue through partnerships, licensing agreements, and future sales of their therapies after regulatory approval.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's recent $450 million funding round provides substantial financial resources to advance its drug pipeline and expand research initiatives.
  • Positive Phase 2 data for plozasiran and the initiation of an Expanded Access Program highlight the company's commitment to addressing unmet medical needs.
  • The company's diversified pipeline, including treatments for cystic fibrosis, hepatitis B, and myotonic dystrophy, offers multiple avenues for success.

What critics are saying

  • The high costs and lengthy timelines associated with drug development could strain Arrowhead's financial resources despite recent funding.
  • Regulatory hurdles and the potential for clinical trial failures pose significant risks to the company's drug approval process.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead Pharmaceuticals leverages RNA interference (RNAi) technology to target and silence disease-causing genes, setting it apart from traditional pharmaceutical approaches.
  • The company's proprietary TRiM platform enables tissue-specific targeting, enhancing the efficacy and safety of its therapies.
  • Strategic partnerships with major pharmaceutical companies like Takeda bolster Arrowhead's credibility and expand its research capabilities.

Help us improve and share your feedback! Did you find this helpful?